Statera Biopharma, Inc. Quarterly Goodwill in USD from Q4 2020 to Q3 2022

Taxonomy & unit: us-gaap: USD
Description: Amount after accumulated impairment loss of an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.
Summary: Statera Biopharma, Inc. quarterly Goodwill history and growth rate from Q4 2020 to Q3 2022.
Statera Biopharma, Inc. Goodwill for the quarter ending September 30, 2022 was $9.27M, a 88% decline year-over-year.

Goodwill, Quarterly (USD)

Goodwill, YoY Quarterly Growth (%)

Period	Value	YoY Chg	Change %	Date	Report	Filed
Q3 2022	$9.27M	-$67.7M	-88%	Sep 30, 2022	10-Q	2022-11-14
Q2 2022	$9.27M			Jun 30, 2022	10-Q	2022-10-28
Q1 2022	$9.27M			Mar 31, 2022	10-Q	2022-10-21
Q4 2021	$9.27M	+$9.27M		Dec 31, 2021	10-Q	2022-11-14
Q3 2021	$77M			Sep 30, 2021	10-Q	2021-11-15
Q4 2020	$0			Dec 31, 2020	10-K	2022-10-06

* An asterisk sign (*) next to the value indicates that the value is likely invalid.